Evidence map›Paper›PMID 34398933›Full record

ArticlePLoS pathogens2021

pUL21 is a viral phosphatase adaptor that promotes herpes simplex virus replication and spread.

Tomasz H Benedyk, Julia Muenzner, Viv Connor, Yue Han, Katherine Brown, Kaveesha J Wijesinghe, Yunhui Zhuang, Susanna Colaco, Guido A Stoll, Owen S Tutt and 8 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 2 countries.

Tomasz H BenedykDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-6420-3665
Julia MuenznerDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-5402-5890
Viv ConnorDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Yue HanDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Katherine BrownDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Kaveesha J WijesingheDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0002-9559-9364
Yunhui ZhuangDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-8941-3749
Susanna ColacoDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-6307-665X
Guido A StollDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-2531-9168
Owen S TuttDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-3045-0355
Stanislava SvobodovaDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Dmitri I SvergunEuropean Molecular Biology Laboratory (EMBL) Hamburg Site, Hamburg, Germany.
Neil A BryantDepartment of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Janet E DeaneCambridge Institute for Medical Research, University of Cambridge, Cambridge Biomedical Campus, Cambridge, United Kingdom.ORCID 0000-0002-4863-0330
Andrew E FirthDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.
Cy M JeffriesEuropean Molecular Biology Laboratory (EMBL) Hamburg Site, Hamburg, Germany.
Colin M CrumpDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0001-9918-9998
Stephen C GrahamDepartment of Pathology, University of Cambridge, Cambridge, United Kingdom.ORCID 0000-0003-4547-4034
University of Cambridge · GBEuropean Molecular Biology Laboratory · DE

Funding

Biotechnology and Biological Sciences Research Council BB/M021424/1Wellcome TrustWellcome Trust 098406/Z/12/BWellcome Trust 106207/Z/14/ZWellcome Trust 219447/Z/19/Z
6 · The paper itself

Abstract

The herpes simplex virus (HSV)-1 protein pUL21 is essential for efficient virus replication and dissemination. While pUL21 has been shown to promote multiple steps of virus assembly and spread, the molecular basis of its function remained unclear. Here we identify that pUL21 is a virus-encoded adaptor of protein phosphatase 1 (PP1). pUL21 directs the dephosphorylation of cellular and virus proteins, including components of the viral nuclear egress complex, and we define a conserved non-canonical linear motif in pUL21 that is essential for PP1 recruitment. In vitro evolution experiments reveal that pUL21 antagonises the activity of the virus-encoded kinase pUS3, with growth and spread of pUL21 PP1-binding mutant viruses being restored in adapted strains where pUS3 activity is disrupted. This study shows that virus-directed phosphatase activity is essential for efficient herpesvirus assembly and spread, highlighting the fine balance between kinase and phosphatase activity required for optimal virus replication.

Indexed as

Virus AssemblyVirus ReplicationAnimalsChlorocebus aethiopsHEK293 CellsHerpes SimplexHerpesvirus 1, HumanHumansPhosphoric Monoester HydrolasesVero CellsViral ProteinsVirus ReleasePhosphoric Monoester HydrolasesViral Proteins

Identifiers

PMID34398933
PMCPMC8389370
OpenAlexW3195526608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.